FDA Import Refusal AEK-3467475-1/21/1 — AbbVie Inc.
The FDA refused shipment AEK-3467475-1/21/1 from AbbVie Inc. (United States) on May 22, 2017. The refused product falls under Drugs and Biologics — TRANDOLAPRIL (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- May 22, 2017
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62OCA11 TRANDOLAPRIL (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75